Nuvectis Pharma Stock (NASDAQ: NVCT) stock price, news, charts, stock research, profile.
You can purchase shares of Nuvectis Pharma (NASDAQ:NVCT) through any online brokerage.
Other companies in Nuvectis Pharma’s space includes: Molecular Partners (NASDAQ:MOLN), Cabaletta Bio (NASDAQ:CABA), Galectin Therapeutics (NASDAQ:GALT), Adaptimmune Therapeutics (NASDAQ:ADAP) and Kyverna Therapeutics (NASDAQ:KYTX).
Nuvectis Pharma has a consensus price target of $21.00.
The stock price for Nuvectis Pharma (NASDAQ: NVCT) is $5.55 last updated November 14, 2024 at 6:56 PM EST.
There are no upcoming dividends for Nuvectis Pharma.
Nuvectis Pharma’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
There is no upcoming split for Nuvectis Pharma.
Nuvectis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.